The Infrastructure and Opportunities Fund (IOF) is a unique feature of the network of investigators, and we can provide a professional and efficient IOF Management Core to administer this program. If selected, we will manage the IOF for the entire network. We will take responsibility for managing the IOF, including disbursement and tracking of IOF funds, establishing an administrative structure to manage the IOF, and reporting on the status of IOF projects and expenditures to the NIAID and MIB Steering Committee. We will support the implementation of the IOF to help the MIB network awardees will work together to facilitate validation and integration of the models being generated, and to build centralized resources, such as common meta-data standards and tools, to facilitate the use of computational models of immunity by the broader research community (e.g., biological ontologies, SBML extensions, annotation standards for computational models of immunity). This core will support these activities and a Steering Committee will be established to serve as the governing board of this collaborative research group.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI117905-01
Application #
8897070
Study Section
Special Emphasis Panel (ZAI1-QV-I (J3))
Project Start
Project End
2016-04-30
Budget Start
2015-05-01
Budget End
2016-04-30
Support Year
1
Fiscal Year
2015
Total Cost
$81,948
Indirect Cost
$16,115
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Crowe Jr, James E (2018) Is It Possible to Develop a ""Universal"" Influenza Virus Vaccine? Potential for a Universal Influenza Vaccine. Cold Spring Harb Perspect Biol 10:
Bangaru, Sandhya; Zhang, Heng; Gilchuk, Iuliia M et al. (2018) A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun 9:2669
Wijesinghe, Kaveesha J; Urata, Sarah; Bhattarai, Nisha et al. (2017) Detection of lipid-induced structural changes of the Marburg virus matrix protein VP40 using hydrogen/deuterium exchange-mass spectrometry. J Biol Chem 292:6108-6122
Crowe Jr, James E (2017) Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design. Cell Host Microbe 22:193-206
Bruhn, Jessica F; Kirchdoerfer, Robert N; Urata, Sarah M et al. (2017) Crystal Structure of the Marburg Virus VP35 Oligomerization Domain. J Virol 91:
Chandra, Vikas; Wu, Dalei; Li, Sheng et al. (2017) The quaternary architecture of RAR?-RXR? heterodimer facilitates domain-domain signal transmission. Nat Commun 8:868
Sangha, Amandeep K; Dong, Jinhui; Williamson, Lauren et al. (2017) Role of Non-local Interactions between CDR Loops in Binding Affinity of MR78 Antibody to Marburg Virus Glycoprotein. Structure 25:1820-1828.e2
Labonte, Jason W; Adolf-Bryfogle, Jared; Schief, William R et al. (2017) Residue-centric modeling and design of saccharide and glycoconjugate structures. J Comput Chem 38:276-287
Tseng, Roger; Goularte, Nicolette F; Chavan, Archana et al. (2017) Structural basis of the day-night transition in a bacterial circadian clock. Science 355:1174-1180
Finn, Jessica A; Koehler Leman, Julia; Willis, Jordan R et al. (2016) Improving Loop Modeling of the Antibody Complementarity-Determining Region 3 Using Knowledge-Based Restraints. PLoS One 11:e0154811

Showing the most recent 10 out of 24 publications